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Abstract
Background: Mutations in the LMNA gene, which encodes all A-type lamins, result in a variety of human diseases termed
laminopathies. Lmna
-/- mice appear normal at birth but become runted as early as 2 weeks of age and develop multiple
tissue defects that mimic some aspects of human laminopathies. Lmna
-/- mice also display smaller spleens and thymuses. In
this study, we investigated whether altered lymphoid organ sizes are correlated with specific defects in lymphocyte
development.
Principal Findings: Lmna
-/- mice displayed severe age-dependent defects in T and B cell development which coincided with
runting. Lmna
-/- bone marrow reconstituted normal T and B cell development in irradiated wild-type recipients, driving
generation of functional and self-MHC restricted CD4
+ and CD8
+ T cells. Transplantation of Lmna
-/- neonatal thymus lobes
into syngeneic wild-type recipients resulted in good engraftment of thymic tissue and normal thymocyte development.
Conclusions: Collectively, these data demonstrate that the severe defects in lymphocyte development that characterize
Lmna
-/- mice do not result directly from the loss of A-type lamin function in lymphocytes or thymic stroma. Instead, the
immune defects in Lmna
-/- mice likely reflect indirect damage, perhaps resulting from prolonged stress due to the striated
muscle dystrophies that occur in these mice.
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Introduction
Nuclear lamins are intermediate filament proteins and have roles in
various nuclear processes, including DNA replication, chromatin
organization, and gene transcription [1–4]. One gene, LMNA,e n c o d e s
the A-type nuclear lamins, which produce the predominant A-type
lamin proteins A and C. Mutations in LMNA are associated with more
than 13 different tissue-specific diseases, collectively termed lamino-
pathies, which include muscular dystrophies, cardiomyopathies, and
more recently, a series of progeroid diseases that resemble some aspects
of premature aging (for review, see Cohen et al.) [5]. Lmna
-/- mice are
characterized by a variety of tissue-specific defects consistent with those
observed in human laminopathies, but additionally display growth
defects as early as 2 weeks of age, reduced thymus and spleen size,
defective spermatogenesis, and death by 6–8 weeks of age [6,7].
A-type lamins have limited expression in the hematopoietic system
[8]. Previous studies describing the presence of lamin A/C proteins in
lymphocyte lineages are mixed, but largely suggest limited to no
presence of A-type lamin proteins in early stages of B and T cell
development, with increasing protein abundance in mature B and T
cells and stimulated lymphocytes [9–13]. Furthermore, A-type lamin
proteins are found only in a minority of cells from the bone marrow,
thymus, spleen, and lymph nodes, which may represent cell types of the
stroma such as epithelial cells, pericytes, inflammatory cells, fibroblasts,
endothelial cells, and smooth muscle cells [8,13–15].
Althoughnoimmunediseasetodate hasbeenlinkedtomutations
in LMNA, Lmna
-/- mice display reduced thymus and spleen size,
suggesting a potential role for A-type lamins in the postnatal
development and/or homeostasis of lymphocyte lineages. Here, we
investigate the reduced thymus and spleen size in Lmna
-/- mice and
identify a progressive, age-dependent impairment in T and B cell
development. These defects are not cell-autonomous, because
transplanted Lmna
-/- bone marrow can reconstitute irradiated
recipient Lmna
+/+ immune tissues. Transplanted Lmna
-/- thymus
lobes show good engraftment in wild-type hosts and drive normal
thymocyte development. Therefore, the altered immune cell
development is not specific to loss of Lmna expression in developing
lymphocytes or thymic epithelial cells, but likely an indirect effect of
loss of lamin expression in other non-lymphoid tissues.
Methods
Mice
Lmna
+/- mice were obtained from Colin Stewart (Institute of
Medical Biology, Immunos Singapore) [7] and sibling mating was
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+/+ and Lmna
-/- mice. This line was also
backcrossed to C57BL/6J (B6) mice for 9 additional generations
and the resulting mice, B6.129S1(Cg)-Lmna
tm1Stw/BkknJ, were
used for thymus transplantation studies. B6.SJL (B6.SJL-Ptprc
a-
Pepc
b/BoyJ) Ly5.1
+ and C57BL/6J Ly5.2
+ mice were crossed to
generate F1 Ly5.1
+Ly5.2
+ mice used as recipients in bone marrow
chimera experiments. Mice were bred and maintained under
specific-pathogen free conditions. All experiments were conducted
in accordance with the review board of the University of
Washington Institutional Animal Care and Use Committee, who
approved this study.
Antibodies and flow cytometry
Single-cell suspensions were prepared from thymus, spleen,
bone marrow, and a pool of brachial, axillary, and inguinal lymph
nodes. Red blood cells were removed from spleen cells by water
lysis. For flow cytometry, Fc receptors were blocked using anti-
CD16/32 (2.4G2; BD Pharmingen). Cells were surface stained in
BSS containing 1% BSA with FITC, phycoerythrin- (PE),
Peridinin-Chlorophyll-Protein-Cy5.5, PE-Cy7, allophycocyanin-
(APC), and APC-AlexaFluor 750 flourochrome-conjugated anti-
bodies and, in some cases, biotinylated antibodies followed by
FITC- or APC-conjugated streptavidin. Antibodies were pur-
chased from BD Pharmingen or eBioscience and included
monoclonal antibodies recognizing mouse CD4 (RM4-5), CD8a
(53–6.7), CD19 (1D3), CD25 (PC61), CD44 (IM7), CD45R/B220
(RA3-6B2), CD62L (MEL-14), CD69 (H1.2F3), panTCRb (H57-
597.13), IgM (II/41), and IgD (11–26c). For intracellular cytokine
staining, splenocytes were incubated for 5 hours at 37uC in RP10
(RPMI with 10% FBS, 10 mM HEPES, 4 mM L-Glutamine,
100 U/ml penicilin, 100 mg/mL streptomycin, 50 mM b-mercap-
toethanol, and 50 mg/mL Gentamycin) in the presence of
GolgiPlug (BD Pharmingen) either in the absence or the presence
of 1 mg/mL GP61–80 I-A
b-restricted peptide (GLKGPDIYKG-
VYQFKSVEFD) for detection of Lymphocytic Choriomeningitis
Virus (LCMV)-specific CD4
+ T cells or 0.1 mg/mL GP33–41 H-
2D
b-restricted peptide (KAVYNFATC) (Invitrogen) for detection
of LCMV-specific CD8
+ T cells [16]. Cells were surface-stained
first, and then stained for intracellular cytokines with APC-
conjugated anti-IFNc (XMG1.2) and PE-conjugated anti-IL-2
(JES6-54H4) or anti-TNFa (MP6-XT22), using the BD Cytofix/
Cytoperm kit and protocol. Flow cytometry data were collected
using a FACS Canto (Becton Dickenson) and analyzed with
FlowJo software (Treestar; Ashland, OR).
Bone marrow chimeras
Single-cell suspensions of hind leg bone marrow from Lmna
+/+
and Lmna
-/- mice were T cell- depleted by staining with PE-
conjugated anti-CD4 and anti-CD8 followed by removal of PE-
labeled cells using the EasySep PE selection separation kit (Stem
Cell Technologies; Vancouver, Canada). Alternatively, T cells
were depleted using anti-Thy1 (13.4.6), anti-CD4 (RL172), and
anti-CD8 (3.168.8) followed by lysis using rabbit complement
(Cedarlane Laboratories Limited; Hornby, Canada). Sex-matched
recipient B6 Ly5.1
+Ly5.2
+ mice were irradiated with 1000 rads 6–
8 hours prior to bone marrow injection, and maintained on
antibiotic water (polymixin B sulfate and neomycin sulfate from
Invitrogen), for 2 days prior to 2 weeks following irradiation.
Recipient mice were injected with 325610
6 T cell-depleted bone
marrow cells into the lateral tail vein.
LCMV infection
Mice were infected by intraperitoneal injection with 2610
5 PFU
of LCMV Armstrong (provided by M.K. Kaja; University of
Washington). Spleens were harvested 8 days later for analysis of
LCMV-specific CD4
+ and CD8
+ T cells by intracellular cytokine
staining and flow cytometry.
Thymic lobe transplantation
Thymic lobes from 1-day-old Lmna
+/+ and Lmna
-/- neonates
were transplanted into 10- to 16-week-old female Lmna
+/+ host
mice by engraftment underneath the kidney capsule. Briefly, 2
days prior through 3 days after surgery, host mice were given
medicated water (ibuprofen 0.2 mg/mL). Neonatal thymic lobes
were placed on sterile nitrocellulose pads and suspended at the
culture medium interface to ensure high oxygen transfer and cell
survival. Thymuses were cultured at 37uC, 5% CO2 for less than
24 hours prior to transplantation while genotypes of extracted
neonatal thymuses were being determined. The culture medium
consisted of DMEM, 10% fetal calf serum, 1 mM sodium
pyruvate, 2 mM L-glutamine, 100 U/mL penicillin, 100 mg/mL
streptomycin, 0.1 mM non-essential amino acids, 0.3% sodium
bicarbonate, 25 mM HEPES, and 50 mM b-mercaptoethanol.
Host mice were anesthetized with ketamine and xylazine
(130 mg/kg and 8.8 mg/kg respectively) and a laparotomy was
performed after hair removal and sterilization of the surgical area.
Thymic lobes were transferred underneath the left kidney capsule.
Host mice were then sutured and monitored until full recovery
from anesthesia. Transplanted thymuses were allowed to engraft
for 6 weeks prior to analysis.
Results
Runting of Lmna
-/- mice is accompanied by progressive
thymic and splenic atrophy
It has been previously reported that Lmna
-/- have mice small
lymphoid organs, including the spleen and thymus [7]. We
analyzed lymphoid organs from Lmna
-/- mice to better understand
the effects of Lmna deficiency on the immune system. Neonatal
Lmna
-/- mice were indistinguishable from Lmna
+/+ littermates 1
week after birth. By 4 weeks of age and older, Lmna
-/- mice were
severely runted compared to Lmna
+/+ mice (Figure 1A). The
thymus and spleen from 6-week old Lmna
-/- mice were reduced in
size (Figure 1B). We observed that while thymic cellularity in
neonatal Lmna
+/+ and Lmna
-/- mice was similar, 4-week old Lmna
-/-
mice displayed decreased thymic cellularity compared to Lmna
+/+
littermates that became more striking with age (Figure 1C).
Similarly, splenic cellularity was unaffected in neonatal Lmna
-/-
mice, but was severely reduced at 4 and 9 weeks of age (Figure 1D).
Thymic and splenic cellularity were reduced even when
normalized to the reduced body weight of Lmna
-/- mice (Figure
S1).
Defective thymocyte maturation in the atrophic Lmna
-/-
thymus
Given the striking decrease in thymic cellularity in Lmna
-/-
mice, we predicted a decrease in the proportion of the
predominant CD4
+CD8
+ double-positive (DP) thymocyte pop-
ulation. Surprisingly, flow cytometric analysis revealed no
perturbation in the frequency of DP thymocytes (Figure 2A
and 2B). Slight reductions were noted in the percent of CD4
single-positive (SP) and CD8 SP thymocytes, starting at 4 weeks
of age. There was also a significant increase in the proportion of
double-negative (DN) thymocytes at 9 weeks of age in Lmna
-/-
mice, possibly indicating that cells are partially blocked in their
developmental progress at one of the DN stages. To further
explore this possibility, we analyzed DN thymocytes, and found
that the percent of DN cells that were DN1 (least mature), DN2,
Lmna
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-/-
mice, indicating that the relative increase in the percent of DN
thymocytes at 9 weeks does not result from a developmental
block at one of the DN stages (Figure S2).
After completion of TCRb rearrangement in the thymus,
cells proliferate at the DN3 to DN4 stage and upregulate CD4
and CD8 coreceptors to become CD4
+CD8
+ DP thymocytes.
At the DP thymocyte stage, cells undergo TCRa rearrange-
ment, and test the newly generated TCRa chain paired with the
already available TCRb chain for the ability to interact with
self-MHC class I and class II molecules. Useful TCR
interactions will result in positive selection of the cell,
upregulation of TCR and CD69 surface expression, and lineage
commitment of CD4 SP and CD8 SP thymocytes. Failure to be
selected results in additional TCRa rearrangement, and
eventually, if no positive selection takes place, the cell under-
goes apoptosis (for review, see Starr et al.)[17]. We observed
that the DPdull (CD4
lowCD8
low) thymocytes, a sub-population
of DP thymocytes that are normally enriched for selected
TCRb
+ cells, lacked positively-selected TCRb
highCD69
+ cells in
9-week-old Lmna
-/- mice (Figure 2C and 2D). Although there
was not a significant decrease in the percent of CD4 SP and
CD8 SP gated thymocytes from 9-week-old Lmna
-/- mice, these
cells displayed clear signs of altered development, including
decreased cell surface TCRb expression for both CD4 SP and
CD8 SP thymocytes, and decreased frequency of post-positive
selection TCRb
+ mature CD8 SP thymocytes (Figure 2E and
2F). Thus, the development of TCRb
+ mature SP thymocytes is
defective in Lmna
-/- mice, suggesting that positive selection is
impaired.
Age-dependent progressive T and B cell lymphopenia in
Lmna
-/- mice
The apparent defect in positive selection in the thymus,
compounded with the reduced thymic size in Lmna
-/- mice,
suggested the size of the peripheral T cell compartment in these
mice would be diminished. To investigate this possibility, we
analyzed splenic CD4
+ and CD8
+ T cells. While Lmna
-/- mice
exhibit an increased percent of splenic CD4
+ and CD8
+ T cells
Figure 1. Age-dependent progressive decrease in body weight and spleen and thymus size in Lmna
-/- mice. Body weight and splenic
and thymic cellularity from Lmna
+/+ and Lmna
-/- mice were determined at 1, 4, and 9 weeks of age. A. Body weight of mice from indicated age groups.
B. Representative thymus and spleen from 6-week-old mice. C. Absolute numbers of thymocytes from mice of the indicated age groups. D. Absolute
numbers of splenocytes from mice of the indicated age groups. Bars show the mean value with error bars indicating the standard deviation (Lmna
+/+
N=3;Lmna
-/- N=3 for each indicated age group). P values were calculated using an unpaired two-tailed Student’s t test (** p,0.001).
doi:10.1371/journal.pone.0010127.g001
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-/- Lymphocyte Defects
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-/- mice display an age-dependent defect in thymic T cell development. Thymocytes were stained for CD4, CD8, CD69, and
panTCRb surface expression. A. Representative flow cytometry plots show CD4/CD8 analysis of live-gated thymocytes. B. Charts show the percent of
thymocytes that are DN, DP, CD4 SP, and CD8 SP for each indicated age group compiled from all mice analyzed. C. CD69/TCRb analysis of
CD4
lowCD8
low gated DP dull cells from 9-week-old mice with a gate indicating the percent of post-selection TCRb
highCD69
+ cells. D. The percent of
CD4
lowCD8
low DP dull cells that are TCRb
highCD69
+ for 4- and 9-week-old mice. E. Histograms of gated CD4 SP and CD8 SP cells showing TCRb
expression. Colored numbers (Blue: Lmna
+/+; Red: Lmna
-/-) in histogram indicate the percent of SP cells that are TCRb
+. F. CD4 SP and CD8 SP gated
thymocytes were analyzed for the percent that are post-positive selection TCRb+ mature SP thymocytes. Charts show the mean percent with error
bars indicating the standard deviation (Lmna
+/+ N=3;Lmna
-/- N=3 for each indicated age group). P values were calculated using an unpaired two-
tailed Student’s t test (* p,0.05, ** p,0.001, *** p,0.0001).
doi:10.1371/journal.pone.0010127.g002
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+/+ mice (Figure 3A), the absolute number of
CD4
+ and CD8
+ T cells is dramatically decreased in Lmna
-/- mice
at both 4 and 9 weeks of age (Figure 3B). These reduced T cell
numbers are a reflection of the loss in absolute numbers of total
splenocytes in the Lmna
-/- mice at these ages (Figure 1D). Given
this severe T cell lymphopenia, we predicted that the remaining T
cells in Lmna
-/- mice would be driven to an activated/memory
CD62L
lowCD44
high phenotype through lymphopenia-induced
homeostatic proliferation. Surprisingly, there was no change in
the percent of CD4
+ and CD8
+ cells that bear an activated/
memory phenotype in 4-week-old (not shown) and 9-week-old
Lmna
-/- spleens (Figure 3C). Although there were subtle increases
Figure 3. T cell and B cell numbers show an age-dependent decline in the lymphoid periphery of Lmna
-/- mice. Splenocytes were
surface stained for CD4, CD8, CD19, CD62L, CD44, and panTCRb. A. Representative flow cytometry plots show the percent of CD4
+ and CD8
+ T cells. B.
Absolute numbers of splenic CD4
+ and CD8
+ T cells for each indicated age group. C. Gated CD4
+ and CD8
+ splenocytes were analyzed for CD62L and
CD44 expression. D. Representative histograms showing the percent of CD19
+ B cells in the spleen. E. Absolute numbers of CD19
+ B cells per spleen
compiled for each indicated age group. Numbers in plots and histograms indicate the percentage of each gated population. Charts show the mean
cell number with error bars indicating the standard deviation (Lmna
+/+ N=3;Lmna
-/- N=3 for each indicated age group). P values were calculated
using an unpaired two-tailed Student’s t test (* p,0.05, ** p,0.001).
doi:10.1371/journal.pone.0010127.g003
Lmna
-/- Lymphocyte Defects
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high and either CD62
low
or CD62L
high in the lymph nodes, these remained dramatically
lower than other mouse systems characterized by T cell
lymphopenia [18,19]. In 9-week-old Lmna
-/- spleens, we also
observed an alteration in the percent of B cells (Figure 3D). This
alteration coincided with a severe reduction in B cell numbers in
the spleen (Figure 3E). Taken together, these data indicate that the
development and/or survival of both B and T lymphocytes is
defective in Lmna
-/- mice.
B cell development is interrupted in Lmna
-/- mice
The cellularity of bone marrow from Lmna
-/- mice was
decreased in 4-week-old mice (Figure 4A). Because splenic B cell
numbers were dramatically reduced in 4- and 9-week-old Lmna
-/-
mice compared to Lmna
+/+ mice, we analyzed bone marrow to
determine whether B cell development was altered. Indeed, the
population of developing B220
+ cells committed to the B cell
lineage was severely reduced in Lmna
-/- mice, and composed
primarily of a B220
high subpopulation (Figure 4B). This reduction
occurred as early as 4 weeks of age in Lmna
-/- mice (Figure 4C and
4D). Of the remaining B220
+ cells in the bone marrow of Lmna
-/-
mice, there was a reduced percent and number of IgM
-IgD
- cells
and IgM
+IgD
- immature B cells, and an increased percent but
normal number of IgM
+IgD
+ mature B cells (Figure 4E and 4F).
Because the developing B220
low IgM
-IgD
- cells and IgM
+IgD
-
immature B cells are so severely affected in Lmna
-/- mice, it is likely
that these B220
high IgM
+IgD
+ mature B cells reached maturity
before these mice experienced the precipitous decline in B cell
development. Therefore, B cell development is impaired in Lmna
-/-
mice with age.
Lmna
-/- B and T cell defects are not cell-autonomous
The alteration in lymphocyte development and homeostasis in
Lmna
-/- mice could result from cell-intrinsic defects caused by Lmna
gene deficiency, from the contribution of A-type lamin function in
non-hematopoietic cells that impact lymphocyte development, or
instead, from the severe pathology and poor health of the Lmna
-/-
mouse. We generated bone marrow chimeras by reconstituting
lethally irradiated Lmna
+/+ mice with Lmna
+/+ or Lmna
-/- bone
marrow to determine whether the defects in T and B cell
development and homeostasis were cell-autonomous. Because
thymocyte and splenocyte defects in Lmna
-/- mice were age-
dependent, we waited .40 weeks after irradiation and reconsti-
tution to analyze the number of Lmna
+/+ and Lmna
-/- populations
in bone marrow, thymus, and spleen of chimeras. Bone marrow
chimeric mice reconstituted with either Lmna
-/- or Lmna
+/+ bone
marrow had similar frequencies and numbers of total bone
marrow cells and B220
+ bone marrow cells (Figure 5A). Bone
marrow chimeras that received either Lmna
-/- or Lmna
+/+ bone
marrow had identical relative and absolute numbers of donor-
derived DN, DP, and SP thymocyte populations (Figure 5B).
Additionally, the relative and absolute number of donor-derived B
and T cells in the spleen were the same in chimeric mice
reconstituted with either Lmna
-/- or Lmna
+/+ bone marrow
(Figure 5C).
To assess the immunocompetence of Lmna
-/- CD4
+ and CD8
+
T cells that appear to develop normally in Lmna
+/+ bone marrow
chimeric hosts, we generated Lmna
+/+/Lmna
-/- mixed bone
marrow chimeras by reconstituting lethally-irradiated Lmna
+/+
mice with a mix of Lmna
+/+ and Lmna
-/- bone marrow. Chimeras
were infected 18 weeks post-reconstitution with the acute virus
LCMV, known to generate a strong virus-specific response from
both CD4
+ and CD8
+ T cells in B6 mice. Eight days later (at the
peak of the T cell response), we analyzed Lmna
+/+ and Lmna
-/-
CD4
+ and CD8
+ T cells for the presence of antigen-specific
effector T cells. IFNc
+, IL-2
+, and TNFa
+ virus-specific effector
cells were present at the same frequencies among both Lmna
+/+
and Lmna
-/- CD4
+ T cells within the same mixed bone marrow
chimera (Figure 6A and 6B). Similarly, virus-specific cytokine-
producing effectors were present at the same frequencies among
Lmna
+/+ and Lmna
-/- CD8
+ T cells (Figure 6C and 6D). These data
show that Lmna
-/- CD4
+ and CD8
+ T cells that develop in an A-
type-lamin-sufficient environment can recognize foreign antigen in
the context of self MHC, and proliferate and produce cytokine
following antigen encounter. Therefore, in a Lmna
+/+ host, Lmna
-/-
T cells are appropriately selected and functional, even when in
direct competition with Lmna
+/+ T cells.
Thus, the splenic and thymic cellularity defects and the
apparent deficiencies in lymphocyte development observed in
Lmna
-/- mice are not cell-autonomous for T or B lymphocytes.
This implies that A-type lamin function/expression is not required
in these cell types for normal development and homeostasis.
Further, it implies the possibility that A-type lamin expression in
non-hematopoietic cells influences the function and development
of these lymphocytes.
Lmna
-/- thymus supports normal T cell development
We examined the possibility that defective T cell development
in Lmna
-/- mice might result from specific defects in thymic stromal
cells, which are required for positive selection of developing DP
thymocytes. To determine whether Lmna
-/- thymic lobes could
foster proper thymocyte development, we transplanted Lmna
-/-
neonatal thymic lobes into adult syngeneic recipients and analyzed
thymic grafts 6 weeks later, after seeding of the lobes with host-
derived Lmna
+/+ stem cells. Grafted Lmna
-/- and Lmna
+/+ thymuses
were similar in appearance and contained similar numbers of
thymocytes (Figure 7A and 7B). Engraftment of both Lmna
+/+ and
Lmna
-/- thymic lobes appeared normal, as both supported a
normal distribution of DN, DP, and CD4 SP and CD8 SP
developing thymocytes (Figure 7C). Unlike the CD4 SP and CD8
SP thymocytes from Lmna
-/- mice (see Figure 2E), CD4 SP and
CD8 SP thymocytes within Lmna
-/- thymuses grafted into Lmna
+/+
hosts had normal TCRb expression and a similar percent of
TCRb+ mature SP thymocytes (Figure 7D). Therefore, Lmna
-/-
thymic stromal cells support normal T cell development when they
are in a healthy, A-type-lamin-sufficient host.
Discussion
In this study, we sought to determine the nature of lymphoid
organ atrophy and lymphocyte population deficiencies in Lmna
-/-
mice. Young adult Lmna
-/- mice exhibit striking decreases in
splenic T and B lymphocyte numbers that correlate with reduced
populations of developing thymocytes and B220
+ B cells in bone
marrow. The apparent selective block in T cell positive selection
and early B cell development in Lmna
-/- mice hinted at specific
developmental checkpoints at which A-type lamin function was
required. However, global reduction in both developing and
mature lymphocytes coincided with the severe runting, as well as
cardiac and skeletal muscle disease onset that occurs in Lmna
-/-
mice [7,20]. In addition, 1-week-old neonatal Lmna
-/- mice are
healthy and indistinguishable from wild-type littermates, with
comparable thymocyte numbers and splenic T and B cell
numbers. These latter observations suggest a more general,
perhaps indirect, impact on lymphocyte development resulting
from the rapidly degrading health of older Lmna
-/- mice.
Bone marrow chimeras were generated to test the possibility
that lamin A/C expression is required in developing lymphocytes
Lmna
-/- Lymphocyte Defects
PLoS ONE | www.plosone.org 6 April 2010 | Volume 5 | Issue 4 | e10127Figure 4. B cell development is impaired in Lmna
-/- mice. Bone marrow single-cell suspensions were stained for surface B220, IgM, and IgD
expression. A. Absolute number of bone marrow cells. B. Representative histograms from 9-week-old mice showing the percent of bone marrow cells
that are developing B220
+ cells. C. The percent of bone marrow cells that are B220
+ for each indicated age group. D. Absolute number of B220
+ bone
marrow cells for each indicated age group. E. Representative IgM/IgD plots of gated B220
+ bone marrow cells from 9-week-old mice. F. Absolute
number of B220
+ bone marrow cells that are IgM
-IgD
-, IgM
+IgD
- (immature B cells), and IgM
+IgD
+ (mature B cells). Numbers in plots and histograms
indicate the percentage of each gated population. Charts show the mean value with error bars indicating the standard deviation (Lmna
+/+ N=3;
Lmna
-/- N=3 for each indicated age group). P values were calculated using an unpaired two-tailed Student’s t test (* p,0.05, ** p,0.001).
doi:10.1371/journal.pone.0010127.g004
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for this, as Lmna
-/- bone marrow completely reconstituted wild-
type recipient mice with normal T and B cell development and
peripheral lymphocyte populations for more than 40 weeks
following bone marrow transfer. Lmna
-/- CD4
+ and CD8
+ T cell
populations in mixed bone marrow chimeras were able to generate
self-MHC class II and class I restricted T cell responses to LCMV
infection. These antigen-specific and differentiated CD4
+IFNc
+
and CD8
+IFNc
+ effector cells were generated at the same
frequency and demonstrated the same cytokine-producing poten-
tial from Lmna
-/- and Lmna
+/+ cells within the same mixed bone
marrow chimeras. These data show that even in differentiated T
cell effector lineages, Lmna gene deficiency has no cell-autonomous
consequence. Together, these data show that intrinsic lamin A/C
expression is not required either for B cell development or for T
cell development and function.
A second possible explanation for the lymphocyte developmen-
tal defects observed in Lmna
-/- mice is that stromal elements within
primary lymphoid organs require lamin A/C expression for their
function in promoting normal T and B cell development. Thymic
epithelial cells play a critical role in the positive selection of
developing thymocytes as rearranged TCRa and TCRb gene
products are tested for useful and safe TCR interactions with self-
MHC:peptide complexes. We tested whether there were thymic
epithelial cell-specific defects in the Lmna
-/- thymus by transplant-
ing mutant thymic lobes into wild-type hosts, and allowing them to
engraft for sufficient time to be seeded by wild-type hematopoietic
stem cells. Within these mice, Lmna
-/- thymic lobes maintained
Figure 5. Lmna
-/- T and B cell defects are not cell-autonomous. Bone marrow chimeras were generated by reconstituting irradiated wild-type
Ly5.1
+Ly5.2
+ mice with bone marrow cells from either Lmna
+/+ or Lmna
-/- Ly5.2
+Ly5.1
- donor mice. Single-cell suspensions from bone marrow,
thymus, and spleen were analyzed 44 weeks following irradiation and bone marrow reconstitution. Cells were stained for surface Ly5.1, Ly5.2, B220,
CD4, CD8, TCRb, and CD19 expression. Donor-derived Ly5.2
+Ly5.1
- cells were analyzed in thymus and spleen. Total bone marrow cells were analyzed
because not all bone marrow cells express Ly5; however, .98% of Ly5
+ cells were donor-derived Ly5.2
+Ly5.1
-, indicating efficient engraftment. A. The
percentage of total bone marrow cells that are B220
+ (left) and the absolute number of total bone marrow cells and B220
+ bone marrow cells (right)
in the indicated bone marrow chimeric mice. B. The percent (left) and absolute number (right) of the indicated donor cells that are DN, DP, CD4 SP,
and CD8 SP thymocytes. C. The percent (left) and absolute number (right) of the indicated donor cells that are CD4
+ T cells, CD8
+ T cells, and CD19
+ B
cells. Charts show the mean percent or number with error bars indicating the standard deviation (Lmna
+/+ into wild-type (WT) chimera N=3; Lmna
-/-
into WT chimera N=5). P values were calculated using an unpaired two-tailed Student’s t test and none reached significance.
doi:10.1371/journal.pone.0010127.g005
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thymic grafts. Thus, Lmna
-/- thymic stroma displayed no cell-
intrinsic defects that can explain the reduced cellularity and
altered thymocyte development observed in Lmna
-/- mice.
However, a formal possibility still exists that defective stromal
elements may influence B cell development in the Lmna
-/- bone
marrow. The stromal and hematopoietic microenvironments in
the bone marrow are different than in the thymus and perhaps
represent more complex interactions with diverse cell types. Of
note, mesenchymal stem cells also inhabit the bone marrow and,
in addition to their role in repopulating tissues of mesenchymal
origin, have a regulatory role stimulating hematopoietic stem cell
growth and differentiation (reviewed in Uccelli, et al.) [21,22].
Because most tissues affected in laminopathy syndromes are of
mesenchymal origin and because recent findings have suggested
that altered A-type lamin function affects the maintenance of
Figure 6. Lmna
-/- T cells in mixed chimeric mice generate functional antigen-specific responses to viral infection. Mixed bone marrow
chimeras were generated by reconstituting irradiated Ly5.1
+Ly5.2
+ mice with a mix of bone marrow cells from Ly5.1
+Ly5.2
2 Lmna
+/+ and Ly5.2+Ly5.1-
Lmna
-/- donor mice. Chimeric mice were infected with LCMV. Eight days later, splenocytes were restimulated with the relevant LCMV peptides for 5
hours, stained for cell surface CD4, CD8, Ly5.1, and Ly5.2 expression, and then stained for intracellular IFNc and IL-2 or TNFa expression. Flow
cytometric analysis allowed for clear separation of Lmna
+/+ (Ly5.1
+Ly5.2
-) and Lmna
-/- (Ly5.1
-Ly5.2
+) donor T cells. A. Representative plots of
intracellular IFNc and IL-2 staining of Lmna
+/+ and Lmna
-/- CD4
+ cells within the same mixed bone marrow chimeric mouse. Antigen-specific CD4
+ T
cells produce cytokine when incubated in the presence of GP61–80 peptide (bottom plots) but not in its absence (top plots). B. The percent LCMV
GP61–80-specific cytokine producing cells of donor-derived CD4
+ T cells. C. Representative plots of intracellular IFNc and IL-2 staining of Lmna
+/+ and
Lmna
-/- CD8
+ cells within the same mixed bone marrow chimeric mouse. Antigen-specific CD8
+ T cells produce cytokine when incubated in the
presence of GP33–41 peptide (bottom plots) but not in its absence (top plots). D. The percent LCMV GP33–41-specific cytokine producing cells of donor-
derived CD8
+ T cells. Numbers in plots indicate the percent of each gated population. Charts show the mean percent with error bars indicating the
standard deviation (Lmna
+/+/Lmna
-/- mixed bone marrow chimeras N=5). P values were calculated using an unpaired two-tailed Student’s t test and
none reached significance.
doi:10.1371/journal.pone.0010127.g006
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defective communication between these cell types could also lead
to altered lymphocyte development. Unfortunately, bone marrow
architecture is difficult to preserve in transplantation studies, and
future studies to address these possibilities will require conditional
deletion of Lmna within select cell types of the bone marrow.
A third possible explanation for the lymphocyte developmental
defects observed in Lmna
-/- mice is an indirect effect of
laminopathies at distal sites. Lmna
-/- mice suffer from stunted
growth and previously characterized cardiac and skeletal muscle
defects contribute to their decline in health and premature death at
around 6–8 weeks of age [7,20,24,25]. Given that A-type lamins
influence a variety of cell types, it is difficult to distinguish between
cell-autonomous defects in specific tissues of Lmna deficiency and
possible indirect effects rendered by so many dystrophic tissues.
Thus, the atrophic lymphoid organs and accompanying reduced
lymphocyte development and maintenance in the Lmna
-/- mice may
resultfromthe overallpoorhealthofthemice.Thesedefectsmaybe
driven by altered stress hormone levels, cytokines from a chronic
inflammatory response to striated muscle dysfunction that is present
in Lmna
-/- mice [7,20,26, Frock et al. manuscript in preparation], or
decreased metabolic function resulting in nutritional deprivation of
lymphocytes. Possibly supporting the argument for a role in
nutritional defects, homeostasis of peripheral T cells appears to be
impaired in Lmna
-/- mice. Despite severe decreases in splenic T cell
numbers, there was no upregulation of CD44 or downregulation of
CD62L in spleen (Figure 3C), changes that characterize T cells that
have undergone lymphopenia-induced homeostatic proliferation.
In summary, we have shown that Lmna
-/- mice undergo a
progressive decline in the size of their thymus and spleen, a decline
of developing B220
+ B cells in the bone marrow, a decline of total
developing thymocytes, and striking decreases in peripheral B and
T cells. All of these changes occurred after 1 week of age, and
coincided with runting of Lmna
-/- mice and onset of multi-tissue
dystrophies. These immune defects were completely rescued when
lymphocyte development was uncoupled from Lmna
-/- animals
through bone marrow chimera and thymic grafting experiments.
We conclude that these effects on lymphocyte development in
Lmna
-/- mice are indirect, and most likely result from an unhealthy
animal that is unable to support normal immune system
development and homeostasis. Our data indicate that even
apparently selective developmental blocks can arise from lympho-
cyte-extrinsic, indirect effects and underscore the need to analyze
lymphocyte development in animals that provide a healthy
environment before concluding that a particular gene or cell type
of interest impacts development of a functional immune system.
Supporting Information
Figure S1 Progressive cellularity defects in spleen and thymus
occur even when organ cellularity is normalized to body weight of
Lmna
-/- mice. A. Thymic and B. splenic cellularity was normalized
to the body weight of each individual mouse of each of the
indicated ages. Charts show the mean normalized value with error
bars indicating the standard deviation (Lmna
+/+ N=3; Lmna
-/-
N=3 for each indicated age group). P values were calculated using
an unpaired two-tailed Student’s t test (* p,0.05, ** p,0.001).
Found at: doi:10.1371/journal.pone.0010127.s001 (0.25 MB TIF)
Figure S2 Normal composition of double-negative DN1-DN4
thymocytes in 9-week old Lmna
-/- mice. Thymocytes from 9-week
old mice were stained for CD4, CD8, CD25, and CD44 surface
expression. DN thymocytes were analyzed for the percent that are
DN1 (CD44
+CD25
2), DN2 (CD44
+CD25
+), DN3 (CD44
2CD25
+),
and DN4 (CD44
2CD25
2). Chart shows the mean percent with
error bars indicating the standard deviation (Lmna
+/+ N=3,Lmna
-/-
N=3). P values were calculated using an unpaired two-tailed
Student’s t test and none reached significance.
Found at: doi:10.1371/journal.pone.0010127.s002 (0.10 MB TIF)
Figure 7. Lmna
-/- thymic lobes support normal T cell develop-
ment in Lmna
+/+ recipients. Thymic lobes from one-day-old Lmna
+/+,
Lmna
+/-, and Lmna
-/- neonates were transplanted under the kidney
capsule of syngenic wild-type recipient mice. Thymic grafts were
analyzed 6 weeks later, allowing sufficient time for seeding by stem
cells from the Lmna
+/+ recipient, promoting subsequent thymocyte
development within the grafted thymus. A. Kidneys of wild-type
recipient mice with grafted Lmna
+/+ and Lmna
-/- thymic lobes. B. The
absolute number of thymocytes within the grafted thymic lobes. C.
Representative flow cytometry plots show CD4/CD8 analysis of live-
gated thymocytes from grafted Lmna
+/+ and Lmna
-/- thymic lobes. D.
Representative histogram overlays of gated CD4 SP and CD8 SP cells
comparing TCRb expression by Lmna
+/+ thymocytes (gray filled
histogram), thymocytes from the Lmna
+/+ graft (blue histogram), and
thymocytes from the Lmna
-/- graft (red histogram). Data are compiled
from two independent experiments.
doi:10.1371/journal.pone.0010127.g007
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